Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
DD ISO TS 80004 โ Nanotechnologies Vocabulary Standard Series (Nano/Bio Interface and Diagnostics and Therapeutics)
Nanotechnologies โ Vocabulary โ Nano/Bio Interface and Diagnostics and Therapeutics for Healthcare (Draft for Development series)
๐ DD ISO/TS 80004 is a British Standards Institution (BSI) “Draft for Development” (DD) series adopting the ISO/TS 80004 (Nanotechnologies โ Vocabulary) technical specifications. Prepared under BSI Technical Committee NTI/1, Nanotechnologies, the series establishes a unified terminology for the rapidly growing nanotechnology field. This batch contains two parts: Part 5 covers the nano/bio interface vocabulary, and Part 7 covers diagnostics and therapeutics for healthcare.
๐ก Terminology unification is the cornerstone of nanotechnology standardisation. Nanomaterials are highly interdisciplinary and cross-industry, and the same concept is often expressed differently in different literature. ISO/TS 80004 defines terms part by part, providing a “common language” for research, regulation and industrial application.
1. Series Overview and Positioning ๐
ISO/TS 80004 is developed under ISO Technical Committee TC 229 (Nanotechnologies) using a “vocabulary split” strategy: the nanotechnology field is divided into topic-specific parts, each defining the core terms of that topic for industry use as needed. BSI adopts it as a DD for UK trial use and experience accumulation.
This batch contains the following two parts:
| Document | Subject | Year | International source | Core content |
|---|---|---|---|---|
| DD ISO/TS 80004-5:2011 | Nanotechnologies โ Vocabulary โ Part 5: Nano/bio interface | 2011 | ISO/TS 80004-5:2011 | Terms and definitions for the interface of nanomaterial interaction with biological systems |
| DD ISO/TS 80004-7:2011 | Nanotechnologies โ Vocabulary โ Part 7: Diagnostics and therapeutics for healthcare | 2011 | ISO/TS 80004-7:2011 | Terms for nanotechnology applications in medical diagnostics, imaging and therapy |
โ ๏ธ When using the ISO/TS 80004 series, note that each part serves a different topic and terms are defined only in the context of that part. When concepts span parts (e.g. nanomaterials in medicine), both relevant branches (e.g. general nanomaterial vocabulary and nanomedicine vocabulary) should be cited for correct context.
2. Nano/Bio Interface Vocabulary (Part 5) ๐งฌ
Part 5 focuses on the nano/bio interface โ the interface region where nanomaterials contact and interact with biological systems (cells, proteins, DNA, etc.). This is foundational vocabulary for nanotoxicology, nanomedicine and nanobiotechnology:
- Nano-bio interaction: the contact, adsorption and response processes of nanomaterials with biological macromolecules, cells and tissues after entering a biological environment.
- Biological barriers and interfaces: interface structures such as cell membranes and the protein corona, which affect the biological fate of nanomaterials.
- Particle size and surface properties: standardised expression of size distribution, surface charge and surface functional groups in biological contexts.
A unified interface vocabulary allows toxicology research, exposure assessment and safety evaluation to be compared across laboratories and literature โ an important basis for nanomaterial risk governance.
3. Healthcare Diagnostics and Therapeutics Vocabulary (Part 7) โ๏ธ
Part 7 addresses diagnostics and therapeutics for healthcare, defining terminology for nanotechnologies in medical applications:
- Nanodiagnostics: diagnostic methods using nanomaterials or nanostructures to improve sensitivity and specificity (e.g. nanolabels, nanosensors).
- Nano-imaging: nano-contrast agents used for medical imaging enhancement (e.g. nanoparticle contrast agents).
- Nanotheranostics/therapy: application of nanomedicine delivery systems and nanocarriers in targeted delivery and treatment.
- Nanomedical devices: terms for clinical products containing nanostructured components.
Standardisation of medical terminology is especially important for regulatory review, clinical trial design and product labelling: only with consistent terms can regulators, physicians and manufacturers communicate indications, mechanisms of action and safety information accurately.
๐ก In healthcare, terminology confusion can lead to review misunderstandings and even safety risk. Part 7 provides the language base for nanomedical products to describe their composition and function accurately to regulators; adopting this vocabulary in registration files and technical documents is recommended.
4. Engineering Practice Points โ๏ธ
- ๐ R&D communication: use the vocabulary consistently in interdisciplinary teams to reduce rework caused by conceptual ambiguity.
- ๐ง Regulatory submission: use standardised terms in medical device and pharmaceutical registration, and nanomaterial safety data sheets, to improve review efficiency.
- ๐ Literature search: unified terminology supports structured databases, improving accuracy of literature retrieval and data analysis.
- ๐ Standard citation: citing the series in technical specifications, procurement and contract documents ensures suppliers and buyers share the same technical language.
5. Frequently Asked Questions โ
โ Q: How does the ISO/TS 80004 series differ from formal ISO standards?
A: ISO/TS denotes a Technical Specification, whose consensus level differs from a formal international standard; it is a provisional document, adopted by BSI as a DD. As the field matures, some content has been progressively absorbed into formal standards.
A: ISO/TS denotes a Technical Specification, whose consensus level differs from a formal international standard; it is a provisional document, adopted by BSI as a DD. As the field matures, some content has been progressively absorbed into formal standards.
โ Q: Why is terminology especially important for nanotechnology?
A: Nanotechnology is highly interdisciplinary and the same concept is expressed differently across industries; unified terminology is the common basis for safety assessment, regulation, intellectual property and commerce.
A: Nanotechnology is highly interdisciplinary and the same concept is expressed differently across industries; unified terminology is the common basis for safety assessment, regulation, intellectual property and commerce.
โ Q: How do the use scenarios of Parts 5 and 7 differ?
A: Part 5 suits fundamental research, toxicology and safety assessment of nano-bio interaction; Part 7 suits medical diagnostics, therapy and device development and registration review.
A: Part 5 suits fundamental research, toxicology and safety assessment of nano-bio interaction; Part 7 suits medical diagnostics, therapy and device development and registration review.
๐ Q: How can the series support regulatory compliance?
A: Using terms as defined in the series in safety data sheets, registration applications and technical documents ensures international alignment and reduces review ambiguity, especially for cross-region product registration.
A: Using terms as defined in the series in safety data sheets, registration applications and technical documents ensures international alignment and reduces review ambiguity, especially for cross-region product registration.